Blocking the TSH receptor with K1-70™ in a patient with follicular thyroid cancer, Graves' disease and Graves' ophthalmopathy-Reference-Cited by-同舟云学术

Blocking the TSH receptor with K1-70™ in a patient with follicular thyroid cancer, Graves' disease and Graves' ophthalmopathy

Published:2021-06-11 Issue: Volume: Page:
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Ryder Mabel¹,Wentworth Mark²,Algeciras-Schimnich Alicia³,Morris John C⁴,Garrity James⁵,Sanders Jane⁶,Young Stuart⁶,Sanders Paul⁶,Furmaniak Jadwiga⁷,Rees Smith Bernard⁶

Affiliation:

1. Mayo Clinic, Endocrinology, Diabetes, Metabolism and Nutrition, 200 First Street SW, Rochester, Minnesota, United States, 55905, ;

2. Mayo Clinic, Endocrinology, Diabetes, Metabolism and Nutrition, Rochester, Minnesota, United States, ;

3. Mayo Clinic Minnesota, 4352, Rochester, Minnesota, United States, ;

4. Mayo Clinic, Endocrinology, 200 First St. SW, Rochester, Minnesota, United States, 55905, , ;

5. mayo clinic, ophthalmology, 200 sw first st, rochester, United States, mn, ;

6. AV7 Limited, Cardiff, United Kingdom of Great Britain and Northern Ireland, ;

7. AV7 Limited, FIRS Laboratories, Parc Ty Glas, Llanishen, Cardiff, United Kingdom of Great Britain and Northern Ireland, CF14 5DU, , ;

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2021.0053

Reference15 articles.

1. ORIGINAL ARTICLE: Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample

2. In vivo effects of a human thyroid-stimulating monoclonal autoantibody (M22) and a human thyroid-blocking autoantibody (K1-70)

3. Effects of TSH Receptor Mutations on Binding and Biological Activity of Monoclonal Antibodies and TSH

4. A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The key data from the 2022 European Thyroid Association congress: Toward personalized treatment of Graves’ orbitopathy;Annales d'Endocrinologie;2023-12

2. Allosteric Sites and Allosteric Regulators of G Protein-Coupled Receptors: Gray Cardinals of Signal Transduction;Journal of Evolutionary Biochemistry and Physiology;2023-12

3. Current and promising therapies based on the pathogenesis of Graves’ ophthalmopathy;Frontiers in Pharmacology;2023-11-16

4. A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves’ orbitopathy;Frontiers in Immunology;2023-01-19

5. Incidence and risk factors for Graves’ orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves’ disease: investigation of 1,553 cases with newly diagnosed Graves’ disease and proposal of a predictive score;Endocrine Journal;2023